Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-011920
Date:2021-03-15
Issuer: FATE THERAPEUTICS INC (FATE)
Original Submission Date:

Reporting Person:

VALAMEHR BAHRAM
C/O FATE THERAPEUTICS, INC.
3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-03-15 M 25,000 d $2.90 120,740 direct
COMMON STOCK 2021-03-15 S 3,957 d $90.89 116,783 direct
COMMON STOCK 2021-03-15 S 8,416 d $91.94 108,367 direct
COMMON STOCK 2021-03-15 S 8,404 d $92.64 99,963 direct
COMMON STOCK 2021-03-15 S 3,205 d $93.75 96,758 direct
COMMON STOCK 2021-03-15 S 1,018 d $94.59 95,740 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.9 2021-03-15 deemed execution date M 25,000 (d) 2026-01-07 common stock 25,000 $2.90 16,156 direct
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a rule 10b5-1 sales plan adopted by the reporting person on june 9, 2020.
f2 represents the weighted average sale price of the shares sold from $90.30 to $91.29 per share. the reporting person will provide, upon request by the commission staff, the issuer or a security holder of he issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
f3 represents the weighted average sale price of the shares sold from $91.30 to $92.29 per share.
f4 represents the weighted average sale price of the shares sold from $92.31 to $93.27 per share.
f5 represents the weighted average sale price of the shares sold from $93.31 to $94.29 per share.
f6 represents the weighted average sale price of the shares sold from $94.40 to $94.90 per share.
f7 this option is fully vested.
WhaleWisdom Logo

Elevate your investments